Table 2

Lipid testing, pharmacologic treatment, and goal attainment among African-American men and women and Caucasian women relative to Caucasian men from logistic regression analyses.*

African American

Caucasian

Women

Odds Ratio

(95% CI)*

Men

Odds Ratio

(95% CI)*

Women

Odds Ratio

(95% CI)*

Men

Reference Group

LDL-C tested (n = 23,104)

0.49 (0.37,0.64)

0.60 (0.47,0.77)

0.80 (0.74,0.86)

1.00

Lipid drug prescribed (n = 14,499)^†

0.62 (0.46,0.83)

0.59 (0.45,0.78)

1.04 (0.95,1.13)

1.00

LDL-C goal attainment (n = 8,336) ^‡

0.55 (0.36,0.82)

0.47 (0.30,0.74)

0.76 (0.68,0.85)

1.00

*Odds ratio and 95% confidence intervals (95% CI) from logistic regression models accounting for within-practice correlations with GEE and controlling for race, sex, age, medical history (diabetes mellitus, myocardial infarction, heart failure, hypertension), and geographic region of medical practice. ^†Regression model includes serum LDL-C concentration. ^‡LDL-C goal attainment (<100 mg/dL) among those with documented LDL-C values and treated with lipid-lowering drugs.

Massing et al. BMC Cardiovascular Disorders 2004 4:15   doi:10.1186/1471-2261-4-15